Affiliations 

  • 1 The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU), Stockholm, Sweden
  • 2 Institut national d'excellence en santé et en services sociaux, Québec, QC, Canada
  • 3 Malaysian Health Technology Assessment Section, Ministry of Health Malaysia, Putrajaya, Malaysia
  • 4 Ontario Health, Toronto, ON, Canada
  • 5 Centre for Drug Evaluation, Taiwan, Republic of China
  • 6 National Institute for Health and Care Excellence, Manchester, United Kingdom
  • 7 Health Technology Wales, Cardiff, United Kingdom
  • 8 Institute of Health Economics, Edmonton, AB, Canada
Int J Technol Assess Health Care, 2024 Dec 10;41(1):e4.
PMID: 39653604 DOI: 10.1017/S0266462324004732

Abstract

Health technology assessment (HTA) agencies assess evidence to support decision making about which technologies to provide and pay for in the health system. HTA impact is understood as the influence that HTA report findings can have in the health system, including impacts on reimbursement decisions, changes to health outcomes, or broader system or societal impacts. The International Network of Agencies for Health Technology Assessment (INAHTA) is a global network of publicly funded HTA agencies. INAHTA's mission, in part, is to advance the impact of HTA to support reimbursement decisions and the optimal use of health system resources. Each year, INAHTA awards the David Hailey Award for Best Impact Story to the member agency that shares the best story, as voted by fellow members, about HTA impact. The impact story sharing program in INAHTA contributes to a deeper understanding of what works well (or not so well) in achieving HTA impact. This paper provides six impact stories from agencies that were finalists for the 2021 and 2022 David Hailey Impact Award for Best Impact Story: the Institut national d'excellence en santé et en services sociaux, the Malaysian Health Technology Assessment Section, Ontario Health, the Center for Drug Evaluation, the National Institute for Health and Care Excellence, and Health Technology Wales. These stories demonstrate that HTA agencies can, in differing ways, effectively support governments in their efforts to place evidence at the centre of decision making.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.